Liberty One Investment Management LLC Purchases 2,133 Shares of Elevance Health, Inc. $ELV

Liberty One Investment Management LLC increased its position in Elevance Health, Inc. (NYSE:ELV) by 20.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,794 shares of the company’s stock after buying an additional 2,133 shares during the quarter. Liberty One Investment Management LLC’s holdings in Elevance Health were worth $4,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of ELV. Nuveen LLC bought a new stake in Elevance Health in the 1st quarter worth approximately $789,943,000. Orbis Allan Gray Ltd lifted its position in Elevance Health by 31.4% in the 1st quarter. Orbis Allan Gray Ltd now owns 2,849,173 shares of the company’s stock worth $1,239,276,000 after buying an additional 680,228 shares during the last quarter. Vanguard Group Inc. increased its stake in Elevance Health by 3.1% in the 1st quarter. Vanguard Group Inc. now owns 22,152,108 shares of the company’s stock worth $9,635,281,000 after purchasing an additional 666,534 shares during the period. Boston Partners increased its stake in Elevance Health by 241.3% in the 1st quarter. Boston Partners now owns 856,737 shares of the company’s stock worth $372,039,000 after purchasing an additional 605,689 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Elevance Health by 13.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,676,203 shares of the company’s stock worth $1,164,041,000 after purchasing an additional 324,040 shares during the period. Institutional investors own 89.24% of the company’s stock.

Insiders Place Their Bets

In other news, Director Susan D. Devore purchased 1,200 shares of Elevance Health stock in a transaction that occurred on Tuesday, August 19th. The shares were bought at an average cost of $312.15 per share, with a total value of $374,580.00. Following the completion of the purchase, the director directly owned 3,502 shares in the company, valued at approximately $1,093,149.30. This trade represents a 52.13% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.29% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. JPMorgan Chase & Co. decreased their price target on Elevance Health from $472.00 to $384.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 22nd. Wall Street Zen cut Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, July 18th. Wells Fargo & Company lifted their price target on Elevance Health from $330.00 to $412.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. The Goldman Sachs Group assumed coverage on Elevance Health in a research note on Tuesday, October 14th. They issued a “neutral” rating and a $343.00 price target on the stock. Finally, Morgan Stanley lifted their price target on Elevance Health from $316.00 to $359.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 14th. Ten investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $400.06.

Elevance Health Price Performance

Shares of ELV stock opened at $354.33 on Tuesday. The stock has a market cap of $79.79 billion, a price-to-earnings ratio of 15.08, a PEG ratio of 1.27 and a beta of 0.59. The business’s fifty day moving average is $323.21 and its 200 day moving average is $354.62. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.64.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.